On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 03/14/23
- ZoomInfo announces $100M share repurchase program
- 02/01/23
- ZoomInfo appoints Ali Dasdan as CTO, Dave Justice as chief revenue officer
- 11/16/22
- ZoomInfo sees 4% sequential growth in Q4, possible 4%-5% per quarter in 2023
- 11/16/22
- ZoomInfo Technologies trading resumes
- 05/01/23
- Woodward jumps over 15% to $114 after Q2 earnings beat, guidance raise
- 04/05/23
- Woodward appoints Bill Lacey as CFO
- 01/30/23
- Woodward boosts dividend 16% to 22c per share
- 12/05/22
- Woodward selected by Airbus to provide Fuel Cell BoP solution
VRTX Vertex Pharmaceuticals - 04/26/23
- Vertex announces U.S. FDA approval for expanded use of Trikafta
- 04/25/23
- Stablix, Vertex collaborate for targeted protein stabilization therapeutics
- 04/10/23
- Sana Biotechnology CMO Sunil Agarwal to leave, Gary Meininger to succeed
- 04/10/23
- Vertex announces Health Canada marketing authorization for ORKAMBI in children
- 04/20/23
- Viper Energy holder Blackstone sells 1.81M shares
- 02/21/23
- Viper Energy sees FY23 production 20-22 MBo/d
TVTX Travere Therapeutics - 05/01/23
- Travere Therapeutics down 24% at $17.25 after announcing sparsentan study data
- 05/01/23
- Travere Therapeutics' sparsentan study did not achieve primary efficacy
- 04/02/23
- Travere Therapeutics announces interim analysis from Phase 3 PROTECT study
- 02/17/23
- Ligand's partner Travere Therapeutics gets FDA accelerated approval of Filspari
- 02/09/23
- Terex raises quarterly dividend 15% to 15c per share
- 02/07/23
- Terex makes equity investment in Texas-based robotics company Apptronik
- 12/19/22
- Terex announces new $150M share repurchase program
- 12/08/22
- Terex appoints Stacey Babson Kaplan Chief Sustainability and Compliance Officer
- 02/17/23
- Stryker's Q Guidance System for cranial applications receives FDA clearance
- 02/13/23
- Stryker exec Menon sells 2,161 common shares
- 02/06/23
- Stryker CFO Boehnlein sells $6.8M in common stock
- 12/07/22
- Stryker raises quarterly dividend 7.9% to 7.5c per share
- 05/01/23
- STAG Industrial to replace Axon in S&P 400 at open on 5/4
- 03/14/23
- Director of STAG Industrial Colbert sells $761K in company shares
- 12/27/22
- SI-Bone announce FDA clearance for iFuse Bedrock Granite
SFM Sprouts Farmers Market - 03/28/23
- Sprouts Farmers Market to eliminate single use plastic bags by end of 2023
- 03/20/23
- Sprouts Farmers Market acquires two licensed stores in California
- 12/08/22
- Sprouts Farmers Market names Alisa Gmelich as SVP, Chief Marketing Officer
- 11/02/22
- Sprouts Farmers Market now available on DoorDash marketplace in select cities
- 03/08/23
- Cassava jumps after director buys over $2.2M of shares
- 02/28/23
- Cassava Sciences announces 2023 scientific goals
- 02/08/23
- Cassava Sciences provides enrollment update for Phase 3 studies of simufilam
- 01/24/23
- Cassava Sciences falls after simufilam data for Alzheimer's disease treatment
- 05/01/23
- Rambus sees Q2 licensing billings $61M-$67M
- 04/25/23
- Rambus CEO sells $617.7K in common stock
- 04/04/23
- Rambus extends patent license agreement with SK hynix
- 02/06/23
- Rambus sees Q1 GAAP licensing billings $61M-$67M
- 03/20/23
- S&P announces changes to S&P 400, 600 indices at open on 3/20
- 01/10/23
- Instructure names Chris Ball as President, COO
- 12/15/22
- Instructure acquires LearnPlatform
- 04/03/23
- FMC Corporation, The HALO Trust partner on farm safety in Ukraine
- 03/13/23
- FMC Corporation: Chief sustainability officer Dr. Karen Totland retires
- 12/14/22
- FMC Corporation CTO Shelton to retire
- 12/06/22
- FMC Corporation, Micropep Technologies announce strategic collaboration
- 02/28/23
- Flowserve, Clariter enter agreement to reduce plastic waste
- 02/28/23
- Flowserve and Clariter sign agreement for chemical recycling plants
- 02/10/23
- Flowserve to acquire Velan in an all cash transaction for $245M
- 01/10/23
- Flowserve to support development of Aramco's Jafurah project
- 05/01/23
- E2open sees Q1 subscription revenue $131M-$134M
- 04/12/23
- E2open, Loadsmart expand strategic partnership
- 02/28/23
- E2open names Jennifer Grafton as General Counsel
- 02/14/23
- Elliott buys NiSource, cuts Aerojet in Q4
- 02/02/23
- Clarus' Black Diamond Equipment appoints Neil Fiske as brand president
- 04/24/23
- Axonics acquired assets of Radian, terms not disclosed
- 01/31/23
- Axonics receives FDA approval for rechargeable sacral neuromodulation system
- 12/13/22
- Axonics announces Health Canada approval of R20 neurostimulator
- 03/10/23
- Arista Networks CEO sells $20.7M in common stock
- 01/24/23
- Arista Networks trading resumes
- 01/24/23
- Arista Networks trading halted, volatility trading pause
- 01/22/23
- Amazon Web Services plans to invest $35B in Virginia by 2040
- 05/01/23
- Addus HomeCare comments on Biden's HHS proposed rule
- 04/24/23 Truist
- Woodward price target lowered to $85 from $93 at Truist
- 02/27/23 Credit Suisse
- Woodward initiated with an Outperform at Credit Suisse
- 02/01/23 Alembic Global
- Woodward upgraded to Overweight from Neutral at Alembic Global
- 01/31/23 Goldman Sachs
- Woodward price target lowered to $74 from $76 at Goldman Sachs
- 02/28/23 Lake Street
- Clarus price target lowered to $20 from $22 at Lake Street
- 02/28/23 BofA
- Clarus price target lowered to $10 from $12 at BofA
- 11/08/22 Lake Street
- Clarus price target lowered to $22 from $35 at Lake Street
- 11/08/22 DA Davidson
- Clarus downgraded to Neutral from Buy at DA Davidson
SFM Sprouts Farmers Market - 04/20/23 Evercore ISI
- Sprouts Farmers Market initiated with an Underperform at Evercore ISI
- 03/08/23 JPMorgan
- Sprouts Farmers Market price target raised to $35 from $33 at JPMorgan
- 03/06/23 R5 Capital
- Sprouts Farmers Market downgraded to Hold from Buy at R5 Capital
- 03/03/23 Deutsche Bank
- Sprouts Farmers Market price target raised to $40 from $38 at Deutsche Bank
- 02/28/23 Truist
- SI-Bone price target raised to $26 from $21 at Truist
- 02/28/23 Needham
- SI-Bone price target raised to $24 from $20 at Needham
- 02/28/23 Canaccord
- SI-Bone price target raised to $24 from $21 at Canaccord
- 02/28/23 Cantor Fitzgerald
- SI-Bone price target raised to $24 from $22 at Cantor Fitzgerald
- 04/18/23 Citi
- Terex price target lowered to $50 from $63 at Citi
- 04/12/23 Deutsche Bank
- Terex price target raised to $53 from $51 at Deutsche Bank
- 03/17/23 BofA
- Terex downgraded to Neutral from Buy at BofA
- 02/15/23 Citi
- Terex downgraded to Neutral from Buy at Citi
- 02/14/23 RBC Capital
- Flowserve price target raised to $30 from $26 at RBC Capital
- 02/13/23 Baird
- Flowserve price target raised to $42 from $32 at Baird
- 01/30/23 BofA
- Flowserve upgraded to Buy at BofA on visibility and valuation
- 01/30/23 BofA
- Flowserve upgraded to Buy from Neutral at BofA
- 05/01/23 JPMorgan
- ZoomInfo price target lowered to $31 from $34 at JPMorgan
- 02/07/23 Morgan Stanley
- ZoomInfo price target lowered to $35 from $38 at Morgan Stanley
- 02/07/23 Wells Fargo
- ZoomInfo price target lowered to $40 from $50 at Wells Fargo
- 02/07/23 Canaccord
- ZoomInfo price target lowered to $35 from $43 at Canaccord
- 12/15/22 Morgan Stanley
- Chegg price target raised to $31 from $24 at Morgan Stanley
- 10/21/22 Citi
- Instructure price target lowered to $27 from $30 at Citi
- 09/01/22 Citi
- Instructure initiated with a Buy at Citi
- 05/03/22 Raymond James
- Instructure price target lowered to $25 from $32 at Raymond James
- 02/09/23 Loop Capital
- Kennametal price target raised to $28 from $22 at Loop Capital
- 02/08/23 Barclays
- Kennametal price target raised to $27 from $25 at Barclays
- 10/03/22 Barclays
- Kennametal price target lowered to $24 from $25 at Barclays
- 08/03/22 Barclays
- Kennametal price target lowered to $25 from $26 at Barclays
- 04/20/23 Roth MKM
- Roth MKM expects slight negative reaction to Blackstone Viper Energy stock sale
- 04/11/23 Truist
- Viper Energy price target raised to $45 from $40 at Truist
- 03/30/23 Stifel
- Viper Energy price target lowered to $33 from $35 at Stifel
- 03/07/23 Piper Sandler
- Viper Energy price target lowered to $38 from $41 at Piper Sandler
- 05/01/23 William Blair
- Addus HomeCare dropped 30% on proposed CMS rule, says William Blair
- 04/28/23 RBC Capital
- Addus HomeCare selloff 'overdone,' says RBC Capital
- 11/02/22 RBC Capital
- Addus HomeCare price target raised to $121 from $110 at RBC Capital
- 08/03/22 Oppenheimer
- Addus HomeCare price target lowered to $130 from $135 at Oppenheimer
LSCC Lattice Semiconductor - 04/11/23 KeyBanc
- Lattice Semiconductor price target raised to $110 from $100 at KeyBanc
- 02/22/23 Baird
- Lattice Semiconductor price target raised to $100 from $75 at Baird
- 02/14/23 Rosenblatt
- Lattice Semiconductor price target raised to $110 from $95 at Rosenblatt
- 02/14/23 Stifel
- Lattice Semiconductor price target raised to $71 from $60 at Stifel
- 02/06/23 BMO Capital
- STAG Industrial initiated with an Outperform at BMO Capital
- 11/22/22 Wells Fargo
- Wells Fargo downgrades STAG Industrial to Equal Weight, lowers target to $34
- 11/22/22 Wells Fargo
- STAG Industrial downgraded to Equal Weight from Overweight at Wells Fargo
- 10/18/22 Wells Fargo
- STAG Industrial price target lowered to $36 from $41 at Wells Fargo
- 01/10/23 UBS
- E2open price target lowered to $6 from $7 at UBS
- 12/16/22 Redburn
- E2open initiated with a Buy at Redburn
- 10/21/22 Goldman Sachs
- E2open initiated with a Neutral at Goldman Sachs
- 09/23/22 Credit Suisse
- E2open initiated with an Underperform at Credit Suisse
- 04/17/23 Evercore ISI
- Arista Networks added to 'Tactical Outperform' list at Evercore ISI
- 04/14/23 Morgan Stanley
- Arista Networks price target raised to $150 from $140 at Morgan Stanley
- 03/22/23 Wells Fargo
- Arista Networks price target raised to $200 from $170 at Wells Fargo
- 03/15/23 Evercore ISI
- Arista Networks can work to '$300+ levels' over time, says Evercore ISI
- 04/23/23 Bernstein
- Stryker price target raised to $336 from $275 at Bernstein
- 04/17/23 Truist
- Stryker price target raised to $300 from $275 at Truist
- 04/17/23 BTIG
- Stryker price target raised to $299 from $281 at BTIG
- 04/17/23 Loop Capital
- Stryker price target raised to $312 from $290 at Loop Capital
- 04/17/23 Truist
- Axonics price target lowered to $73 from $82 at Truist
- 04/13/23 Mizuho
- Axonics initiated with a Buy at Mizuho
- 03/24/23 Needham
- Needham upgrades Axonics to Buy on conservative guidance, attractive valuation
- 03/24/23 Needham
- Axonics upgraded to Buy from Hold at Needham
- 04/21/23 Mizuho
- FMC Corporation price target raised to $150 from $147 at Mizuho
- 03/17/23 Redburn
- FMC Corporation upgraded to Buy from Neutral at Redburn
- 02/14/23 Goldman Sachs
- FMC Corporation price target raised to $159 from $155 at Goldman Sachs
- 02/09/23 BMO Capital
- FMC Corporation price target raised to $145 from $140 at BMO Capital
- 04/24/23 Deutsche Bank
- Rambus price target raised to $55 from $45 at Deutsche Bank
- 04/24/23 Susquehanna
- Rambus weak server demand poses near-term risk, says Susquehanna
- 02/03/23 Susquehanna
- Rambus price target raised to $60 from $36 at Susquehanna
- 01/30/23 Deutsche Bank
- Rambus price target raised to $45 from $34 at Deutsche Bank
VRTX Vertex Pharmaceuticals - 03/29/23 Raymond James
- Bluebird Bio reaction to lovo-cel BLA delay 'overdone,' says Raymond James
- 03/29/23 Argus
- Vertex Pharmaceuticals price target raised to $350 from $340 at Argus
- 03/21/23 Bernstein
- Vertex Pharmaceuticals initiated with an Outperform at Bernstein
- 03/01/23 Guggenheim
- Immunogen confident in early Elahere launch, says Guggenheim
- 01/25/23 B. Riley
- Cassava Sciences price target lowered to $28 from $44 at B. Riley
- 01/24/23 H.C. Wainwright
- H.C. Wainwright positive on Cassava data, says buy the selloff
- 11/29/22 Univest Securities
- Cassava Sciences price target lowered to $11 from $12 at Univest Securities
- 11/16/22 B. Riley
- Cassava Sciences downgraded to Neutral at B. Riley amid limited disclosures
TVTX Travere Therapeutics - 04/10/23 Guggenheim
- Travere Therapeutics price target raised to $40 from $37 at Guggenheim
- 04/04/23 Barclays
- Travere risk/reward positive into FSGS data, says Barclays
- 03/13/23 Piper Sandler
- Travere Therapeutics price target lowered to $41 from $44 at Piper Sandler
- 02/28/23 Guggenheim
- Travere Therapeutics initiated with a Buy, $37 price target at Guggenheim
- 05/01/23
- ZoomInfo sees FY23 adjusted EPS 99c-$1.01 vs. prior 98c-$1.00
- 05/01/23
- ZoomInfo sees Q2 adjusted EPS 22c-23c, consensus 23c
- 05/01/23
- ZoomInfo reports Q1 EPS 24c, consensus 22c
- 05/01/23
- Woodward sees FY23 EPS $3.50-$3.75, consensus $3.18
- 05/01/23
- Woodward reports Q2 EPS $1.01, consensus 72c
- 01/30/23
- Woodward backs FY23 EPS view $3.15-$3.60, consensus $3.39
- 01/30/23
- Woodward reports Q1 EPS 49c, consensus 63c
VRTX Vertex Pharmaceuticals - 05/01/23
- Vertex Pharmaceuticals backs FY23 revenue view of $9.55B-$9.7B, consensus $9.71B
- 05/01/23
- Vertex Pharmaceuticals reports Q1 EPS $2.69, consensus $3.00
- 02/07/23
- Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B
- 02/07/23
- Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51
- 05/01/23
- Viper Energy reports Q1 EPS 47c, consensus 41c
- 02/21/23
- Viper Energy reports Q4 adjusted EPS 28c, consensus 41c
- 11/07/22
- Viper Energy reports Q3 EPS 98c, consensus 57c
TVTX Travere Therapeutics - 02/23/23
- Travere Therapeutics reports Q4 EPS ($1.03), consensus ($1.07)
- 01/09/23
- Travere Therapeutics sees Q4 net product sales $52M, consensus $57.15
- 05/01/23
- Terex raises FY23 EPS view to $5.60-$6.00 from $4.60-$5.00, consensus $4.91
- 05/01/23
- Terex reports Q1 EPS $1.60, consensus $1.04
- 02/09/23
- Terex sees FY23 EPS $4.60-$5.00, consensus $4.78
- 02/09/23
- Terex reports Q4 EPS $1.34, consensus $1.13
- 05/01/23
- Stryker sees FY23 adjusted EPS $10.05-$10.25, consensus $10.03
- 05/01/23
- Stryker reports Q1 EPS $2.14, consensus $2.00
- 01/31/23
- Stryker sees FY23 adjusted EPS $9.85-$10.15, consensus $9.86
- 04/26/23
- STAG Industrial reports Q1 core FFO 55c, consensus 55c
- 02/15/23
- STAG Industrial reports Q4 core FFO 55c, consensus 56c
- 05/01/23
- SI-Bone raises FY23 revenue view to $128M-$131M from $124M-$127M
- 05/01/23
- SI-Bone reports Q1 EPS (32c), consensus (41c)
- 02/27/23
- SI-Bone sees FY23 revenue $124M-$127M, consensus $125.3M
- 02/27/23
- SI-Bone reports Q4 EPS (32c), consensus (40c)
SFM Sprouts Farmers Market - 05/01/23
- Sprouts Farmers Market sees FY23 adjusted EPS $2.58-$2.68, consensus $2.48
- 05/01/23
- Sprouts Farmers Market sees Q2 adjusted EPS 61c-65c, consensus 59c
- 05/01/23
- Sprouts Farmers Market reports Q1 EPS 73c, consensus 85c
- 05/01/23
- Notable companies reporting after market close
- 05/01/23
- Cassava Sciences reports Q1 EPS (58c) vs (44c) last year
- 02/28/23
- Cassava Sciences reports Q4 EPS (47c), consensus (56c)
- 11/07/22
- Cassava Sciences reports Q3 EPS (51c), consensus (48c)
- 05/01/23
- Rambus reports Q1 EPS 3c vs. (60c) last year
- 02/06/23
- Rambus sees Q1 EPS 13c-20c, consensus 42c
- 02/06/23
- Rambus reports Q4 EPS 14c vs. 5c last year
LSCC Lattice Semiconductor - 05/01/23
- Lattice Semiconductor sees Q2 revenue $183M-$193M, consensus $183.87M
- 05/01/23
- Lattice Semiconductor reports Q1 adjusted EPS 51c, consensus 50c
- 02/13/23
- Lattice Semiconductor sees Q1 revenue $175M-$185M, consensus $174.7M
- 02/13/23
- Lattice Semiconductor reports Q4 EPS 49c, consensus 48c
- 05/01/23
- Kennametal raises FY23 adjusted EPS view to $1.50-$1.70 from $1.30-$1.70
- 05/01/23
- Kennametal reports Q3 EPS 39c, consensus 34c
- 02/06/23
- Kennametal reaffirms FY23 adjusted EPS view $1.30-$1.70, consensus $1.47
- 02/06/23
- Kennametal sees Q3 revenue $520M-$540M, consensus $510.46M
- 05/01/23
- Instructure sees FY23 revenue $521.3M-$525.3M, consensus $521.98M
- 05/01/23
- Instructure sees Q2 revenue $128.5M-$129.5M, consensus $125.13M
- 05/01/23
- Instructure reports Q1 non-GAAP EPS 19c, consensus 18c
- 02/13/23
- Instructure sees FY23 revenue $519.4M-$523.4M, consensus $520.93M
- 05/01/23
- FMC Corporation sees Q2 adjusted EPS $1.66-$1.86, consensus $1.92
- 05/01/23
- FMC Corporation narrows FY23 adjusted EPS view to $7.34-$7.94 from $7.20-$8.00
- 05/01/23
- FMC Corporation reports Q1 adjusted EPS $1.77, consensus $1.75
- 02/08/23
- FMC Corporation sees Q1 adjusted EPS $1.63-$1.83, consensus $1.87
- 05/01/23
- Flowserve raises FY23 adjusted EPS view to $1.65-$1.85 from $1.50-$1.75
- 05/01/23
- Flowserve reports Q1 adjusted EPS 40c, consensus 25c
- 02/21/23
- Flowserve sees FY23 adjusted EPS $1.50-$1.75, consensus $1.67
- 02/21/23
- Flowserve reports Q4 adjusted EPS 63c, consensus 53c
- 05/01/23
- E2open sees FY24 revenue $655M-$670M, consensus $657.15M
- 05/01/23
- E2open reports Q4 adjusted EPS 7c, consensus 7c
- 01/09/23
- E2open cuts FY23 revenue view to $655M-$660M, consensus $669.7M
- 01/09/23
- E2open reports Q3 EPS 6c, consensus 7c
- 05/01/23
- Clarus sees FY23 revenue approximately $420M $, consensus $420.48M
- 05/01/23
- Clarus reports Q1 EPS $18c, consensus 20c
- 02/27/23
- Clarus sees FY23 revenue $420M, consensus $457.39M
- 02/27/23
- Clarus reports Q4 adjusted EPS 20c, consensus 22c
- 05/01/23
- Axonics raises FY23 revenue view to $348M from $324M, consensus $347.8M
- 05/01/23
- Axonics reports Q1 EPS (19c), consensus (29c)
- 03/01/23
- Axonics backs FY23 revenue view of $342M, consensus $336.4M
- 03/01/23
- Axonics reports Q4 EPS 1c, consensus (24c)
- 05/01/23
- Arista Networks sees Q2 revenue $1.35B-$1.4B, consensus $1.35B
- 05/01/23
- Arista Networks reports Q1 adjusted EPS $1.43, consensus $1.34
- 02/13/23
- Arista Networks sees FY23 revenue $5.47B, consensus $5.4B
- 05/01/23
- Addus HomeCare reports Q1 adjusted EPS 97c, consensus 87c
- 02/27/23
- Addus HomeCare reports Q4 adjusted EPS $1.11, consensus 95c
|